CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 enrolled
Drug / intervention
Casein phosphopeptide-amorphous calcium phosphate +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06821724
NCT06821724N/ACompleted
CompareCT.gov

Comparative Study on the Effect of Different Remineralizing Agents Versus Fluoride Gel on White Spot Lesions After In-Office Followed by Home Treatment in Children: A Randomized Controlled Clinical Study

National Research Centre, Egypt·interventional·Posted Feb 12, 2025·Updated Feb 12, 2025

In Brief

A clinical study evaluating Casein phosphopeptide-amorphous calcium phosphate, Casein phosphopeptide-amorphous calcium phosphate + fluoride, and 2 other interventions for White Spot Lesion of Tooth. Completed, enrolled 100 participants across 1 site.

Detailed Summary

One hundred children with white spot lesions on their teeth were divivided into 5 groups of different remineralizing agents to assess their effect on color change and remineralization

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsWhite Spot Lesion of Tooth
CountriesEgypt
Collaborators--

Timeline

N/ACompletedFinished
20252026
First PostedFeb 12, 2025
Enrollment StartDec 1, 2024
Primary CompletionJan 15, 2025
Study CompletionFeb 1, 2025
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 1.4 years ago

Interventions

Casein phosphopeptide-amorphous calcium phosphatedrug

Intervention

Casein phosphopeptide-amorphous calcium phosphate + fluoridedrug

Intervention

Nano hydroxyapatite pastedrug

Intervention

Fluoride geldrug

Positive control